ASX - By Stock
|
OIL |
Re:
Optiscan Improving Cancer Outcomes with Digital Pathology & Precision Surgery
|
|
PeterMBA
|
16 |
13K |
10 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
16
|
13K
|
10
|
|
ASX - By Stock
|
OIL |
Re:
Optiscan Improving Cancer Outcomes with Digital Pathology & Precision Surgery
|
|
PeterMBA
|
16 |
13K |
13 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
16
|
13K
|
13
|
|
ASX - By Stock
|
OIL |
Re:
Optiscan Improving Cancer Outcomes with Digital Pathology & Precision Surgery
|
|
PeterMBA
|
16 |
13K |
9 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
16
|
13K
|
9
|
|
ASX - By Stock
|
OIL |
Re:
Optiscan Improving Cancer Outcomes with Digital Pathology & Precision Surgery
|
|
PeterMBA
|
16 |
13K |
7 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
16
|
13K
|
7
|
|
ASX - By Stock
|
OIL |
Optiscan Improving Cancer Outcomes with Digital Pathology & Precision Surgery
|
|
PeterMBA
|
16 |
13K |
14 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
16
|
13K
|
14
|
|
ASX - By Stock
|
OIL |
Paula Fox Melanoma and Cancer Centre – New Project
|
|
PeterMBA
|
0 |
5.3K |
13 |
25/06/23 |
25/06/23 |
ASX - By Stock
|
0
|
5.3K
|
13
|
|
ASX - By Stock
|
OIL |
Optiscan’s True Asset Value Exceeds $1 Billion
|
|
PeterMBA
|
8 |
7.4K |
12 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
8
|
7.4K
|
12
|
|
ASX - By Stock
|
OIL |
Should the Royal Melbourne Hospital buy 19 of Optiscan’s InVivage devices After TGA approval in the future?
|
|
PeterMBA
|
19 |
7.1K |
10 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
19
|
7.1K
|
10
|
|
ASX - By Stock
|
OIL |
Charlie Teo is not the real issue – Effective cancer removal is – Digital Technology required
|
|
PeterMBA
|
5 |
3.7K |
15 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
5
|
3.7K
|
15
|
|
ASX - By Stock
|
OIL |
No Night Shift Pathology services for Physical Biopsy Analysis – Urgent Need for Digital Biopsies
|
|
PeterMBA
|
4 |
4.8K |
17 |
11/02/23 |
11/02/23 |
ASX - By Stock
|
4
|
4.8K
|
17
|
|
ASX - By Stock
|
OIL |
Digital biopsy - a safe guard to prevent mistakes and more
|
|
PeterMBA
|
0 |
3.4K |
8 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
0
|
3.4K
|
8
|
|
ASX - By Stock
|
OIL |
Physical Biopsy Failures – Cross Contamination of Sample – Is there an alternative?
|
|
PeterMBA
|
0 |
3.4K |
9 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
0
|
3.4K
|
9
|
|
ASX - By Stock
|
OIL |
Re:
Tiresias: Getting to Good News
|
|
PeterMBA
|
2 |
10K |
7 |
27/02/22 |
27/02/22 |
ASX - By Stock
|
2
|
10K
|
7
|
|
ASX - By Stock
|
OIL |
Re:
Optiscan is 100000% more significant than Cochlear
|
|
PeterMBA
|
39 |
34K |
1 |
27/02/22 |
27/02/22 |
ASX - By Stock
|
39
|
34K
|
1
|
|
ASX - By Stock
|
COH |
Optiscan is 100000% more significant than Cochlear
|
|
PeterMBA
|
1 |
9.2K |
0 |
27/02/22 |
27/02/22 |
ASX - By Stock
|
1
|
9.2K
|
0
|
|
ASX - By Stock
|
OIL |
Re:
Ann: Appendix 4D and 31 December 2021 Half-year report
|
|
PeterMBA
|
5 |
2.0K |
0 |
27/02/22 |
27/02/22 |
ASX - By Stock
|
5
|
2.0K
|
0
|
|
ASX - By Stock
|
OIL |
Re:
New Email Address for Shareholders to Communicate
|
|
PeterMBA
|
1 |
4.1K |
8 |
27/02/22 |
27/02/22 |
ASX - By Stock
|
1
|
4.1K
|
8
|
|
ASX - By Stock
|
OIL |
New Email Address for Shareholders to Communicate
|
|
PeterMBA
|
1 |
4.1K |
5 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
1
|
4.1K
|
5
|
|
ASX - By Stock
|
OIL |
Re:
Tiresias: Whither current pathology?
|
|
PeterMBA
|
7 |
15K |
0 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
7
|
15K
|
0
|
|
ASX - By Stock
|
OIL |
What are the human cancers that Optiscan’s technology could be used on?
|
|
PeterMBA
|
0 |
16K |
7 |
15/02/22 |
15/02/22 |
ASX - By Stock
|
0
|
16K
|
7
|
|
ASX - By Stock
|
OIL |
Re:
Tiresias: Whither current pathology?
|
|
PeterMBA
|
7 |
15K |
3 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
7
|
15K
|
3
|
|
ASX - By Stock
|
OIL |
Re:
Tiresias: Whither current pathology?
|
|
PeterMBA
|
7 |
15K |
3 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
7
|
15K
|
3
|
|
ASX - By Stock
|
OIL |
Mauna Kea Technologies is not as good as Optiscan
|
|
PeterMBA
|
0 |
8.7K |
7 |
12/02/22 |
12/02/22 |
ASX - By Stock
|
0
|
8.7K
|
7
|
|
ASX - By Stock
|
OIL |
Optiscan is 100000% more significant than Cochlear
|
|
PeterMBA
|
39 |
34K |
12 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
39
|
34K
|
12
|
|
ASX - By Stock
|
OIL |
Re:
Tiresias: Something Close and Personal
|
|
PeterMBA
|
3 |
10K |
5 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
3
|
10K
|
5
|
|
ASX - By Stock
|
OIL |
Re:
Optiscan News
|
|
PeterMBA
|
2 |
3.1K |
6 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
2
|
3.1K
|
6
|
|
ASX - By Stock
|
OIL |
Re:
Convivo
|
|
PeterMBA
|
7 |
7.0K |
0 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
7
|
7.0K
|
0
|
|
ASX - By Stock
|
OIL |
Re:
Public Information/Education Campaign Required
|
|
PeterMBA
|
3 |
3.0K |
7 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
3
|
3.0K
|
7
|
|
ASX - By Stock
|
OIL |
Public Information/Education Campaign Required
|
|
PeterMBA
|
3 |
3.0K |
7 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
3
|
3.0K
|
7
|
|
ASX - By Stock
|
OIL |
Re:
Optiscan AGM 11am Thursday 20 January
|
|
PeterMBA
|
2 |
5.7K |
0 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
2
|
5.7K
|
0
|
|
ASX - By Stock
|
OIL |
Re:
Optiscan AGM 11am Thursday 20 January
|
|
PeterMBA
|
2 |
5.7K |
0 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
2
|
5.7K
|
0
|
|
ASX - By Stock
|
OIL |
Optiscan AGM 11am Thursday 20 January
|
|
PeterMBA
|
2 |
5.7K |
6 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
2
|
5.7K
|
6
|
|
ASX - By Stock
|
OIL |
Spread the News - World leading technology
|
|
PeterMBA
|
6 |
10K |
12 |
06/01/22 |
06/01/22 |
ASX - By Stock
|
6
|
10K
|
12
|
|
ASX - By Stock
|
OIL |
Covid-19 Question
|
|
PeterMBA
|
1 |
779 |
1 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
1
|
779
|
1
|
|